Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

artificial intelligence AI in healthcare

Providers, payers share actionable experiences involving healthcare AI

A large venture capital firm focused on supporting early-stage healthtech companies has a tip for AI startups targeting the healthcare sector.

Anthem

Anthem BCBS reverses course on anesthesia time limits

After announcing it would place time limits on reimbursement for the time a patient is under anesthesia, Anthem Blue Cross Blue Shield has now denied it ever intended to make the change. 

UnitedHealthcare CEO Brian Thompson

Photo released of suspect in murder of UnitedHealthcare CEO as details emerge

The NYPD is offering a $10,000 award for “information leading to an arrest and conviction.” No arrests have been made and the killer has yet to be identified. 

The rapid rise of artificial intelligence (AI) has helped cardiologists, radiologists, nurses and other healthcare providers embrace precision medicine in a way that ensures more heart patients are receiving personalized care.

Up to half of medical organizations either already using or preparing to implement AI

With the number of FDA approved AI-enabled applications nearing 1,000, it’s clear the healthcare industry is ready to embrace the evolving technology.

partnership business deal joint venture

Interventional cardiology’s first Match Day celebrated as a ‘historic achievement’

This was a moment years in the making for interventional cardiology. A total of 164 training programs participated, and 94% of applicants secured a position. 

artificial intelligence money finance acquisition

Cleerly’s momentum continues as AI specialists raise $106M

The news comes at the end of a busy year for Cleerly. The company says it will use the funds to grow commercially and generate more evidence in support of its FDA-approved technology.

A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]

AI-powered ECG screening a cost-effective way to ID heart failure patients

The technique was especially cost-effective in outpatient settings, according to a new study of more than 22,000 patients.

FDA issues Class I recall on insulin syringes due to risk of death

A line of syringes manufactured by Cardinal Health may fail to properly inject insulin when used with needleless IV connectors.